Product
AD-224C
Aliases
Placebo of AD-224C
1 clinical trial
1 indication
Indication
Hypertension,EssentialClinical trial
A Randomization, Double-blind, Active-controlled, Multicenter, Phase 3 Trial to Evaluate the Efficacy and Safety of AD-224A and AD-224B in Patients With Essential HypertensionStatus: Not yet recruiting, Estimated PCD: 2024-12-01